JP2009520463A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009520463A5 JP2009520463A5 JP2008542539A JP2008542539A JP2009520463A5 JP 2009520463 A5 JP2009520463 A5 JP 2009520463A5 JP 2008542539 A JP2008542539 A JP 2008542539A JP 2008542539 A JP2008542539 A JP 2008542539A JP 2009520463 A5 JP2009520463 A5 JP 2009520463A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- polypeptide
- heptapeptide
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002773 nucleotide Substances 0.000 claims 136
- 125000003729 nucleotide group Chemical group 0.000 claims 136
- 108090000765 processed proteins & peptides Proteins 0.000 claims 132
- 229920001184 polypeptide Polymers 0.000 claims 129
- 102000004196 processed proteins & peptides Human genes 0.000 claims 129
- 230000027455 binding Effects 0.000 claims 121
- 239000000203 mixture Substances 0.000 claims 79
- 125000003275 alpha amino acid group Chemical group 0.000 claims 63
- 125000000539 amino acid group Chemical group 0.000 claims 60
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 49
- 239000011701 zinc Substances 0.000 claims 49
- 229910052725 zinc Inorganic materials 0.000 claims 49
- 238000006467 substitution reaction Methods 0.000 claims 27
- 229910052717 sulfur Inorganic materials 0.000 claims 27
- 229910052739 hydrogen Inorganic materials 0.000 claims 24
- 102000040430 polynucleotide Human genes 0.000 claims 23
- 108091033319 polynucleotide Proteins 0.000 claims 23
- 239000002157 polynucleotide Substances 0.000 claims 23
- 229910052722 tritium Inorganic materials 0.000 claims 16
- 108090000623 proteins and genes Proteins 0.000 claims 12
- 239000003937 drug carrier Substances 0.000 claims 11
- 239000008194 pharmaceutical composition Substances 0.000 claims 11
- 108091023040 Transcription factor Proteins 0.000 claims 10
- 102000040945 Transcription factor Human genes 0.000 claims 10
- 229910052757 nitrogen Inorganic materials 0.000 claims 9
- 150000007523 nucleic acids Chemical group 0.000 claims 9
- 230000002103 transcriptional effect Effects 0.000 claims 9
- 241000713772 Human immunodeficiency virus 1 Species 0.000 claims 7
- 102000003964 Histone deacetylase Human genes 0.000 claims 6
- 108090000353 Histone deacetylase Proteins 0.000 claims 6
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 6
- 238000010494 dissociation reaction Methods 0.000 claims 6
- 230000005593 dissociations Effects 0.000 claims 6
- 150000001413 amino acids Chemical class 0.000 claims 4
- 230000010076 replication Effects 0.000 claims 4
- 125000003412 L-alanyl group Chemical group [H]N([H])[C@@](C([H])([H])[H])(C(=O)[*])[H] 0.000 claims 3
- 125000000570 L-alpha-aspartyl group Chemical group [H]OC(=O)C([H])([H])[C@]([H])(N([H])[H])C(*)=O 0.000 claims 3
- 125000002059 L-arginyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H] 0.000 claims 3
- 125000000010 L-asparaginyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C(=O)N([H])[H] 0.000 claims 3
- 125000000415 L-cysteinyl group Chemical group O=C([*])[C@@](N([H])[H])([H])C([H])([H])S[H] 0.000 claims 3
- 125000003338 L-glutaminyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C(=O)N([H])[H] 0.000 claims 3
- 125000002066 L-histidyl group Chemical group [H]N1C([H])=NC(C([H])([H])[C@](C(=O)[*])([H])N([H])[H])=C1[H] 0.000 claims 3
- 125000002061 L-isoleucyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])[C@](C([H])([H])[H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims 3
- 125000001176 L-lysyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C([H])([H])C([H])([H])C([H])([H])C(N([H])[H])([H])[H] 0.000 claims 3
- 125000002842 L-seryl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])O[H] 0.000 claims 3
- 125000000769 L-threonyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])[C@](O[H])(C([H])([H])[H])[H] 0.000 claims 3
- 125000002707 L-tryptophyl group Chemical group [H]C1=C([H])C([H])=C2C(C([C@](N([H])[H])(C(=O)[*])[H])([H])[H])=C([H])N([H])C2=C1[H] 0.000 claims 3
- 125000003580 L-valyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(C([H])([H])[H])(C([H])([H])[H])[H] 0.000 claims 3
- 102100025169 Max-binding protein MNT Human genes 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 238000000302 molecular modelling Methods 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 229910052698 phosphorus Inorganic materials 0.000 claims 3
- 108091006106 transcriptional activators Proteins 0.000 claims 3
- 108091008023 transcriptional regulators Proteins 0.000 claims 3
- 108091006107 transcriptional repressors Proteins 0.000 claims 3
- 230000004568 DNA-binding Effects 0.000 claims 2
- 101710185494 Zinc finger protein Proteins 0.000 claims 2
- 102100023597 Zinc finger protein 816 Human genes 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 1
- 108010077805 Bacterial Proteins Proteins 0.000 claims 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 claims 1
- 101710163270 Nuclease Proteins 0.000 claims 1
- 108700001094 Plant Genes Proteins 0.000 claims 1
- 108700005077 Viral Genes Proteins 0.000 claims 1
- 230000003197 catalytic effect Effects 0.000 claims 1
- 238000003776 cleavage reaction Methods 0.000 claims 1
- 102000037983 regulatory factors Human genes 0.000 claims 1
- 108091008025 regulatory factors Proteins 0.000 claims 1
- 230000007017 scission Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74052505P | 2005-11-28 | 2005-11-28 | |
| PCT/US2006/061289 WO2007062422A2 (en) | 2005-11-28 | 2006-11-28 | Zinc finger binding domains for tnn |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009520463A JP2009520463A (ja) | 2009-05-28 |
| JP2009520463A5 true JP2009520463A5 (cg-RX-API-DMAC7.html) | 2010-01-14 |
Family
ID=38068069
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008542539A Pending JP2009520463A (ja) | 2005-11-28 | 2006-11-28 | Ｔｎｎのための亜鉛フィンガー結合ドメイン |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7833784B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1963499A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2009520463A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2631422A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007062422A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7329728B1 (en) * | 1999-10-25 | 2008-02-12 | The Scripps Research Institute | Ligand activated transcriptional regulator proteins |
| CA2631422A1 (en) | 2005-11-28 | 2007-05-31 | The Scripps Research Institute | Zinc finger binding domains for tnn |
| CA2638823A1 (en) | 2006-02-13 | 2007-08-23 | Alethia Biotherapeutics Inc. | Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| US8168181B2 (en) | 2006-02-13 | 2012-05-01 | Alethia Biotherapeutics, Inc. | Methods of impairing osteoclast differentiation using antibodies that bind siglec-15 |
| US20090081786A1 (en) * | 2006-06-30 | 2009-03-26 | Viktoria Kheifets | Peptide sequences for modulation of protein kinase C |
| WO2009042164A1 (en) * | 2007-09-27 | 2009-04-02 | Dow Agrosciences Llc | Engineered zinc finger proteins targeting 5-enolpyruvyl shikimate-3-phosphate synthase genes |
| CN102027118B (zh) | 2008-04-30 | 2014-07-30 | 桑比欧公司 | 含有dna甲基化状态改变的神经再生细胞 |
| WO2010056808A2 (en) * | 2008-11-12 | 2010-05-20 | The Regents Of The University Of California | Compositions and methods for re-programming and re-differentiating cells |
| WO2011017315A2 (en) | 2009-08-03 | 2011-02-10 | Recombinetics, Inc. | Methods and compositions for targeted gene modification |
| US8956828B2 (en) | 2009-11-10 | 2015-02-17 | Sangamo Biosciences, Inc. | Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases |
| EP2694554A1 (en) | 2011-04-08 | 2014-02-12 | Gilead Biologics, Inc. | Methods and compositions for normalization of tumor vasculature by inhibition of loxl2 |
| JP6023218B2 (ja) | 2012-01-27 | 2016-11-09 | サンバイオ，インコーポレイティド | 血管新生及び血管発生を調節するための方法及び組成物 |
| US11120889B2 (en) | 2012-05-09 | 2021-09-14 | Georgia Tech Research Corporation | Method for synthesizing a nuclease with reduced off-site cleavage |
| MX2015000863A (es) | 2012-07-19 | 2016-05-05 | Alethia Biotherapeutics Inc | Anticuerpos anti-siglec-15. |
| KR102271292B1 (ko) | 2013-03-15 | 2021-07-02 | 더 제너럴 하스피탈 코포레이션 | Rna-안내 게놈 편집의 특이성을 증가시키기 위한 rna-안내 foki 뉴클레아제(rfn)의 용도 |
| WO2014186435A2 (en) | 2013-05-14 | 2014-11-20 | University Of Georgia Research Foundation, Inc. | Compositions and methods for reducing neointima formation |
| US11918695B2 (en) | 2014-05-09 | 2024-03-05 | Yale University | Topical formulation of hyperbranched polymer-coated particles |
| EP3721875B1 (en) | 2014-05-09 | 2023-11-08 | Yale University | Particles coated with hyperbranched polyglycerol and methods for their preparation |
| AU2017221424A1 (en) | 2016-02-16 | 2018-09-20 | Yale University | Compositions and methods for treatment of cystic fibrosis |
| US11136597B2 (en) | 2016-02-16 | 2021-10-05 | Yale University | Compositions for enhancing targeted gene editing and methods of use thereof |
| WO2017173453A1 (en) | 2016-04-01 | 2017-10-05 | The Brigham And Women's Hospital, Inc. | Stimuli-responsive nanoparticles for biomedical applications |
| EP3448997B1 (en) | 2016-04-27 | 2020-10-14 | Massachusetts Institute of Technology | Stable nanoscale nucleic acid assemblies and methods thereof |
| WO2017189914A1 (en) | 2016-04-27 | 2017-11-02 | Massachusetts Institute Of Technology | Sequence-controlled polymer random access memory storage |
| WO2018081138A1 (en) | 2016-10-24 | 2018-05-03 | Yale University | Biodegradable contraceptive implants |
| US11371023B2 (en) * | 2016-11-22 | 2022-06-28 | Wisconsin Alumni Research Foundation | Artificial transcription factors and uses thereof |
| US20200085758A1 (en) | 2016-12-16 | 2020-03-19 | The Brigham And Women's Hospital, Inc. | Co-delivery of nucleic acids for simultaneous suppression and expression of target genes |
| WO2018187493A1 (en) | 2017-04-04 | 2018-10-11 | Yale University | Compositions and methods for in utero delivery |
| EP3612204A4 (en) | 2017-04-21 | 2021-01-27 | The General Hospital Corporation | INDUCTIBLE, TUNING AND MULTIPLEX HUMAN GENE REGULATION USING CRISPR-CPF1 |
| US10940171B2 (en) | 2017-11-10 | 2021-03-09 | Massachusetts Institute Of Technology | Microbial production of pure single stranded nucleic acids |
| EP3713644B1 (en) | 2017-11-20 | 2024-08-07 | University of Georgia Research Foundation, Inc. | Compositions and methods for modulating hif-2a to improve muscle generation and repair |
| AU2019269692A1 (en) * | 2018-05-17 | 2020-11-19 | The General Hospital Corporation | CCCTC-binding factor variants |
| US11939593B2 (en) | 2018-08-01 | 2024-03-26 | University Of Georgia Research Foundation, Inc. | Compositions and methods for improving embryo development |
| CA3111186A1 (en) | 2018-08-31 | 2020-03-05 | Yale University | Compositions and methods for enhancing triplex and nuclease-based gene editing |
| JP7570107B2 (ja) | 2018-08-31 | 2024-10-21 | イェール ユニバーシティー | ドナーオリゴヌクレオチドベースの遺伝子編集を亢進するための組成物および方法 |
| WO2020112195A1 (en) | 2018-11-30 | 2020-06-04 | Yale University | Compositions, technologies and methods of using plerixafor to enhance gene editing |
| US11419932B2 (en) | 2019-01-24 | 2022-08-23 | Massachusetts Institute Of Technology | Nucleic acid nanostructure platform for antigen presentation and vaccine formulations formed therefrom |
| US11905532B2 (en) | 2019-06-25 | 2024-02-20 | Massachusetts Institute Of Technology | Compositions and methods for molecular memory storage and retrieval |
| US12485180B2 (en) | 2019-08-30 | 2025-12-02 | Yale University | Compositions and methods for delivery of nucleic acids to cells |
| MX2023002480A (es) | 2020-08-31 | 2023-05-18 | Univ Yale | "composiciones y métodos para el suministro de ácidos nucleicos a las células. |
| CN117321197A (zh) | 2021-01-12 | 2023-12-29 | 马奇疗法公司 | 背景依赖性、双链dna特异性脱氨酶及其用途 |
| WO2022170117A1 (en) * | 2021-02-04 | 2022-08-11 | New York University | Seamless integration of engineered zinc fingers into endogenous transcription factors to commandeer their natural functions |
| WO2023070043A1 (en) | 2021-10-20 | 2023-04-27 | Yale University | Compositions and methods for targeted editing and evolution of repetitive genetic elements |
| US20230302423A1 (en) | 2022-03-28 | 2023-09-28 | Massachusetts Institute Of Technology | Rna scaffolded wireframe origami and methods thereof |
| CN119584991A (zh) | 2022-07-22 | 2025-03-07 | 约翰霍普金斯大学 | 树枝状大分子介导的靶向细胞内crispr/cas系统递送和基因编辑 |
| WO2024081736A2 (en) | 2022-10-11 | 2024-04-18 | Yale University | Compositions and methods of using cell-penetrating antibodies |
| JP2025540052A (ja) | 2022-12-01 | 2025-12-11 | イェール ユニバーシティー | 細胞内ペイロード送達用刺激応答性トレースレス操作プラットフォーム |
| WO2025224715A1 (en) | 2024-04-26 | 2025-10-30 | King Abdullah Univeristy Of Science And Technology | Methods for improving precise genome modification and reducing unwanted mutations by crispr-cas editing |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5096815A (en) * | 1989-01-06 | 1992-03-17 | Protein Engineering Corporation | Generation and selection of novel dna-binding proteins and polypeptides |
| JP3393867B2 (ja) | 1989-11-13 | 2003-04-07 | マサチユーセツツ・インステイテユート・オブ・テクノロジー | ウィルムス腫瘍遺伝子の位置決定と特徴付け |
| CA2181548C (en) | 1994-01-18 | 2009-11-03 | Carlos F. Barbas, Iii | Zinc finger protein derivatives and methods therefor |
| USRE45721E1 (en) | 1994-08-20 | 2015-10-06 | Gendaq, Ltd. | Relating to binding proteins for recognition of DNA |
| US5789538A (en) * | 1995-02-03 | 1998-08-04 | Massachusetts Institute Of Technology | Zinc finger proteins with high affinity new DNA binding specificities |
| US6140081A (en) * | 1998-10-16 | 2000-10-31 | The Scripps Research Institute | Zinc finger binding domains for GNN |
| US6599692B1 (en) * | 1999-09-14 | 2003-07-29 | Sangamo Bioscience, Inc. | Functional genomics using zinc finger proteins |
| US7067617B2 (en) * | 2001-02-21 | 2006-06-27 | The Scripps Research Institute | Zinc finger binding domains for nucleotide sequence ANN |
| WO2003016496A2 (en) * | 2001-08-20 | 2003-02-27 | The Scripps Research Institute | Zinc finger binding domains for cnn |
| WO2003066828A2 (en) * | 2002-02-07 | 2003-08-14 | The Scripps Research Institute | Zinc finger libraries |
| CA2631422A1 (en) | 2005-11-28 | 2007-05-31 | The Scripps Research Institute | Zinc finger binding domains for tnn |
-
2006
- 2006-11-28 CA CA002631422A patent/CA2631422A1/en not_active Abandoned
- 2006-11-28 JP JP2008542539A patent/JP2009520463A/ja active Pending
- 2006-11-28 WO PCT/US2006/061289 patent/WO2007062422A2/en not_active Ceased
- 2006-11-28 EP EP06846383A patent/EP1963499A4/en not_active Ceased
- 2006-11-28 US US11/564,141 patent/US7833784B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009520463A5 (cg-RX-API-DMAC7.html) | ||
| JP7741218B2 (ja) | 抗炎症活性を有するペプチド、及びそれを含む組成物 | |
| JP6546232B2 (ja) | 抗炎症活性を有するペプチド、及びそれを含む組成物 | |
| US8710015B2 (en) | Tropoelastin derivatives | |
| Itoh et al. | Molecular cloning and sequence determination of cDNAs for alpha subunits of the guanine nucleotide-binding proteins Gs, Gi, and Go from rat brain. | |
| Arning et al. | Mammalian splicing factor SF1 is encoded by variant cDNAs and binds to RNA. | |
| JP4006021B2 (ja) | ケモカインの生物学的活性の強化法 | |
| JP4902352B2 (ja) | トランスフォーミング増殖因子β１（ＴＧＦ−β１）との結合能を有するペプチド | |
| Ramirez et al. | Molecular characterization and evolution of a duck mitochondrial genome | |
| HUT70459A (en) | Analogs of pth | |
| Takahashi et al. | Evolutionarily conserved non-AUG translation initiation in NAT1/p97/DAP5 (EIF4G2) | |
| Huang et al. | Molecular cloning and expression analysis of a fish specific interferon regulatory factor, IRF11, in orange spotted grouper, Epinephelus coioides | |
| KR102569494B1 (ko) | Cd44의 단리된 폴리펩타이드 및 이의 사용 | |
| JPWO2008081812A1 (ja) | 抗腫瘍ペプチド及びその利用 | |
| Wassarman et al. | The Drosophila melanogaster ribosomal S6 kinase II-encoding sequence | |
| JP2009504156A5 (cg-RX-API-DMAC7.html) | ||
| Yao et al. | Structure of the N-terminal domain of the effector protein LegC3 from Legionella pneumophila | |
| KR102307567B1 (ko) | 항염증 활성을 갖는 펩티드 및 이를 포함하는 조성물 | |
| CN107868119B (zh) | 用于抑制cd279相互作用的组合物和方法 | |
| Coutte et al. | Cloning and expression analysis of a cDNA that encodes a leech hemerythrin | |
| Arakawa et al. | Molecular cloning, characterization, and chromosomal mapping of a novel human gene (GTF3A) that is highly homologous to Xenopus transcription factor IIIA | |
| Brand et al. | Novel Drosophila melanogaster genes encoding RRM-type RNA-binding proteins identified by a degenerate PCR strategy | |
| CN114437196A (zh) | 一种抑制SARS-CoV-2感染的蛋白及其用途 | |
| Luo et al. | Direct cDNA cloning of novel conotoxins of the T-superfamily from Conus textile | |
| WO2000031252A1 (en) | Human semaphorin 6a-1 (sema6a-a), a gene involved in neuronal development and regeneration mechanisms during apoptosis, and its use as a potential drug target |